Bladder Cancer Treatments
Thursday, September 17, 2026
University of Illinois Cancer Center member Karine Tawagi, MD, a practicing medical oncologist at UI Health, discussed evolving treatments in muscle-invasive bladder cancer on an episode of MedNews Week, presented in partnership with OncoDaily TV.
Tawagi discussed emerging perioperative chemoimmunotherapy, antibody-drug conjugates, immune checkpoint inhibitors, and biomarker-driven strategies on the episode, which aired earlier in September. She specializes in the treatment of genitourinary cancers, including, but not limited to, bladder, kidney, testicular, and prostate cancers.
The Cancer Center is part of UI Health, the academic health enterprise at the University of Illinois Chicago (UIC). She is a member of the Translational Oncology Research Program at the Cancer Center.
